| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |